Are These 28 European Countries About to Open the Door to Monsanto Company?

Will GMOs soon be as synonymous with Europe as vineyards? Source: Andrei Stroe/ Wikimedia Commons.

Europe has long taken a precautionary approach when dealing with biotech crops. Twenty-eight of the 64 countries globally that require labels for food products containing ingredients produced from genetically modified organisms reside in the European Union. And, while the import and cultivation of biotech crops is only banned outright in one European nation, only five European Union members -- the Czech Republic, Portugal, Romania, Slovakia, and Spain -- grow biotech crops at all (and not much). Their combined production amounts to less than one-thousandth of the world's total agricultural output.

Now, nearly 20 years after biotech crops debuted commercially, all of that may be about to change. A new policy being considered by the European Union will aim to give individual member nations more autonomy over the crops they cultivate, and clean up fragmented policies around the continent. That could be big news for plant-trait developers and biotech-seed producers such as Monsanto Company (NYSE: MON  ) , Syngenta (NYSE: SYT  )  and The Dow Chemical Company (NYSE: DOW  ) . Not only would they be able to sell engineered seeds directly to European farmers, but American farmers could gain an important market for exports. A policy shift could have major global economic advantages -- investors included! -- by the end of the decade.

The importance of European agriculture
China, South America, and the United States -- home to some of the world's best farmland -- have gladly taken the plunge with biotech crops, and have reaped significant rewards. Meanwhile, other leading breadbaskets such as Africa, the European Union, and Russia have largely refrained from cultivating biotech crops due to extreme caution, propaganda, and/or poor science. There would be profound consequences if any one of these leading agricultural regions pivoted, however, especially Europe. Consider the importance of European farmland for major world crops compared to other major regions:

No, Europe won't suddenly decide to plant large swaths of corn and soybeans if new policy is introduced, but we may see new traits and engineered seeds for the continent's staple crops, wheat and sugar beets. That could create a massive potential boon for Monsanto, Syngenta, and The Dow Chemical Company shareholders -- all of which actually have robust operations in Europe at the moment.

 

Monsanto Company 2013 Sales

Syngenta 2013 Sales

North America

$9.13 billion

$3.85 billion

Europe, Africa, Middle East

$2.04 billion

$4.22 billion

South America

$2.67 billion

$3.99 billion

Asia-Pacific

$806 million

$1.93 billion

 

   

Total Sales

$14.9 billion

$13.99 billion*

*Excludes Lawn and Garden segment. Source: Monsanto Company, Syngenta.

Remember, each company can be broken down into two business segments: (1) seeds and traits, and (2) crop protection. Products and services offered to customers around the world include genetic traits, engineered seeds, "organic" seeds, agricultural oils, fungicides, insecticides, herbicides, and more. The growth I'm focusing on in this article would be derived from the ability to sell large quantities of traits and engineered seeds to the European market, although crop protection products would also come along for the ride.

By the numbers
How would it work? I envision growth in two parts. First, all three companies could capture continued growth for traits and seeds traditionally associated with American agriculture, such as corn and soybeans. Consider the breakdown of Monsanto Company's sales in the most recent fiscal year:

 

2013 Sales

% of Total Segment Sales

Corn Traits & Seeds

$6.6 billion

63.8%

Soybean Traits & Seeds

$1.6 billion

15.5%

Cotton Traits & Seeds

$700 million

6.7%

Other Seeds & Traits

$575 million

5.5%

Vegetable seeds

$821 million

7.9%

 

   

Total Seed and Genomics Segment Sales

$10.34 billion

100%

Source: SEC filings, Monsanto Company.

Syngenta boasts smaller sales in seeds and traits -- making most of its revenue from crop protection products -- but is an industry force nonetheless:

 

2013 Sales

% of Total Segment Sales

Corn and Soybean

$1.7 billion

51.6%

Diverse Field Crops

$842 million

26.3%

Vegetables

$708 million

22.1%

 

   

Total Seed Segment Sales

$3.20 billion

100%

Source: Syngenta (link opens PDF).

The Dow Chemical Company doesn't breakdown its agricultural business, Dow AgroSciences, but it has grown by at least 10% in each of the last three years, and sported total revenue of $7.14 billion in 2013. Since roughly 25% of the company's revenue was derived seeds, traits, and oils, let's use $1.7 billion for comparison to the companies above. Of course, it's important to stress that not all sales above are from engineered seeds; but you can see that the American agriculture market dominates -- and roughly dictates -- Monsanto Company's portfolio, and heavily influences those of its peers.

The second wave of growth would come from new traits altogether, tailored to the European market. Take wheat as the perfect example. While enhanced wheat varieties have failed to gain commercial traction in the United States -- North and South America account for just 17.5% of global wheat production -- in part due to import restrictions in Europe, the 28-member union, which accounts for one-third of global production, could turn the tide. New policy could open the door for genomic trait and seed companies to the massive global cereal market, which has been untouched by biotechnology. Most cereal production resides in Asia and Europe, but American farmers would gain an important and new market for exports. It would be a win-win for global agriculture.

Foolish bottom line
It's still amazing to think that the massive successes of the seed and trait segments at Monsanto Company, Syngenta, and The Dow Chemical Company have mostly come after the commercial use of biotech crops in 1996 -- starting from scratch with less defined tools and policies. The game is much different today.

Growth in Europe, whether from established or novel biotech products, could be expedited by leveraging relationships with existing customers -- assuming, of course, European farmers are interested. Acquisitions could be made to gain access to specific regions and markets, if necessary. It may sound a bit optimistic today, but it really isn't unrealistic to believe Europe could single-handedly change the world's attitude toward the marriage of biotechnology and agriculture. Savvy investors looking to global trading and market trends could stand to benefit.

Old agriculture tech may soon be worthless -- much like your credit card
Biotech crops have become an important agricultural tool for the world's farmers, and may soon push older, less-efficient production methods out of the market. Similar market forces are doing the same to credit cards. An eye-opening new presentation reveals the full story on why your credit card is about to be worthless -- and highlights one little-known company sitting at the epicenter of an earth-shaking movement that could hand early investors the kind of profits we haven't seen since the dot-com days. Click here to watch this stunning video.


Read/Post Comments (3) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On July 20, 2014, at 11:52 PM, getthefacts4 wrote:

    small point, there imports of GM grains to the EU. Its really cultivation that's the issue

  • Report this Comment On July 20, 2014, at 11:57 PM, getthefacts4 wrote:

    i.e. GM soy and corn animal feed from the US is imported now but not cultivated as you mentioned. The EU uses GM enzyme in cheese and wine but that is exempt otherwise they would have to stop production. Problem is only crops tolerant to some herbicides are relevant - not so many insect problems. The EU prefers to spray highly toxic insecticides and fungicides- guess what the many EU companies make pesticides not GM crops so it isn't likely to change - they haven't bothered to produce fungal tolerant GM crops

  • Report this Comment On July 21, 2014, at 9:43 AM, TMFBlacknGold wrote:

    @getthefacts4

    Right, and new potential policy will allow individual member nations to make their own decision regarding the cultivation of biotech crops.

    From the article:

    "A new policy being considered by the European Union will aim to give individual member nations more autonomy over the crops they cultivate, and clean up fragmented policies around the continent."

    Maxxwell

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 3033907, ~/Articles/ArticleHandler.aspx, 10/24/2014 6:20:37 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement